Rodgers Brothers Inc. Has $4.30 Million Stock Position in Revvity, Inc. (NYSE:RVTY)

Rodgers Brothers Inc. raised its stake in Revvity, Inc. (NYSE:RVTY) by 1.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,506 shares of the company’s stock after purchasing an additional 425 shares during the quarter. Rodgers Brothers Inc.’s holdings in Revvity were worth $4,298,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the stock. Victory Capital Management Inc. increased its holdings in Revvity by 17.4% during the fourth quarter. Victory Capital Management Inc. now owns 70,250 shares of the company’s stock worth $7,841,000 after buying an additional 10,390 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Revvity by 13.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company’s stock valued at $43,961,000 after purchasing an additional 41,497 shares during the last quarter. Contravisory Investment Management Inc. grew its holdings in Revvity by 1,715.9% during the fourth quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company’s stock worth $7,722,000 after purchasing an additional 65,376 shares during the period. FMR LLC increased its position in Revvity by 40.8% during the third quarter. FMR LLC now owns 155,556 shares of the company’s stock worth $19,872,000 after buying an additional 45,040 shares during the last quarter. Finally, Janney Montgomery Scott LLC raised its stake in Revvity by 87.0% in the fourth quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company’s stock valued at $881,000 after buying an additional 3,672 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Trading Down 1.6 %

RVTY opened at $105.65 on Monday. The company’s 50 day moving average is $115.16 and its 200-day moving average is $117.14. The company has a market cap of $12.69 billion, a P/E ratio of 47.81, a PEG ratio of 3.82 and a beta of 1.06. Revvity, Inc. has a 1-year low of $97.32 and a 1-year high of $129.50. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the prior year, the firm earned $1.25 earnings per share. Equities research analysts predict that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.27%. The ex-dividend date is Thursday, April 17th. Revvity’s dividend payout ratio is currently 12.67%.

Insider Activity at Revvity

In other Revvity news, insider Tajinder S. Vohra sold 5,492 shares of the company’s stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the sale, the insider now owns 19,652 shares in the company, valued at approximately $2,295,550.12. The trade was a 21.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Joel S. Goldberg sold 15,170 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares of the company’s stock, valued at $4,232,782. This trade represents a 31.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.68% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

RVTY has been the subject of a number of research reports. Barclays raised their target price on shares of Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Bank of America upgraded Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price on the stock in a research note on Friday, December 13th. Raymond James restated an “outperform” rating and issued a $145.00 price target (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Sanford C. Bernstein cut Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price objective on the stock. in a research report on Friday, January 10th. Finally, KeyCorp boosted their target price on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Four equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $136.25.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.